IONS
Ionis Pharmaceuticals, Inc.
Stock
$43.54−0.46 (−1.05%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $134M
- YoY, 2025
- +2.8%
- 5-year CAGR
- −10.3%
- 10-year CAGR
- +8.5%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $134M | +2.8% |
| 2024 | $130M | +23.1% |
| 2023 | $106M | +5.5% |
| 2022 | $100M | −16.9% |
| 2021 | $121M | −47.6% |
| 2020 | $230M | +57.0% |
| 2019 | $147M | +11.6% |
| 2018 | $131M | +52.7% |
| 2017 | $86M | +19.2% |
| 2016 | $72M | +21.6% |
| 2015 | $59M | +89.0% |
| 2014 | $31M | +174.9% |
| 2013 | $11M | +33.2% |
| 2012 | $8.6M | −12.9% |
| 2011 | $9.8M | −19.0% |
| 2010 | $12M | −9.2% |
| 2009 | $13M | −11.1% |
| 2008 | $15M | — |